Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Quality Index
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Quality Index of 0.92x as of December 2019. Operating cash flow of $12.36 Million is below net income of $13.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Enanta Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Enanta Pharmaceuticals Inc Cash Flow Quality Index (2010–2019)
Historical Cash Flow Quality Index for Enanta Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ENTA cash generation efficiency.
Annual Cash Flow Quality Index for Enanta Pharmaceuticals Inc (2010–2019)
Year-by-year earnings quality comparison for Enanta Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.54x | $71.42 Million | $46.38 Million | ▲ +279.2% |
| 2018 | 0.41x | $29.22 Million | $71.96 Million | ▼ -86.3% |
| 2017 | 2.97x | $52.65 Million | $17.71 Million | ▲ +79.9% |
| 2016 | 1.65x | $35.81 Million | $21.67 Million | ▲ +70.3% |
| 2015 | 0.97x | $76.67 Million | $78.99 Million | ▲ +65.7% |
| 2014 | 0.59x | $20.18 Million | $34.44 Million | ▼ -47.0% |
| 2013 | 1.11x | $10.65 Million | $9.63 Million | ▲ +4.7% |
| 2012 | 1.06x | $22.62 Million | $21.40 Million | ▲ +2.6% |
| 2011 | 1.03x | $24.02 Million | $23.31 Million | ▲ +180.0% |
| 2010 | -1.29x | $-10.18 Million | $7.90 Million | — |